These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33008656)

  • 1. Improving risk-equalization in Switzerland: Effects of alternative reform proposals on reallocating public subsidies for hospitals.
    Beck K; Kauer L; McGuire TG; Schmid CPR
    Health Policy; 2020 Dec; 124(12):1363-1367. PubMed ID: 33008656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-insurance in the Swiss health insurance market: Fit, power, and balance.
    Schmid CP; Beck K
    Health Policy; 2016 Jul; 120(7):848-55. PubMed ID: 27157115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk equalization and voluntary deductibles: a complex interaction.
    van Kleef RC; Beck K; van de Ven WP; van Vliet RC
    J Health Econ; 2008 Mar; 27(2):427-43. PubMed ID: 18178276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of market reforms and new public management mechanisms on the Swiss health care system.
    Moresi-Izzo S; Bankauskaite V; Gericke CA
    Int J Health Plann Manage; 2010; 25(4):368-85. PubMed ID: 20540084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extreme under and overcompensation in morbidity-based health plan payments: The case of Switzerland.
    Kauer L; McGuire TG; Beck K
    Health Policy; 2020 Jan; 124(1):61-68. PubMed ID: 31818483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in The drivers of health expenditures financed by health insurance in a fragmented health system: The case of Switzerland.
    Eggli Y; Stadelmann P; Piaget-Rossel R; Marti J
    Health Policy; 2019 Dec; 123(12):1275-1281. PubMed ID: 31706633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What drives public health care expenditure growth? Evidence from Swiss cantons, 1970-2012.
    Braendle T; Colombier C
    Health Policy; 2016 Sep; 120(9):1051-60. PubMed ID: 27496155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new prevention paradox: the trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers.
    Kanters TA; Brouwer WB; van Vliet RC; van Baal PH; Polder JJ
    Soc Sci Med; 2013 Jan; 76(1):150-8. PubMed ID: 23182593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the prediction model used in risk equalization: cost and diagnostic information from multiple prior years.
    van Veen SH; van Kleef RC; van de Ven WP; van Vliet RC
    Eur J Health Econ; 2015 Mar; 16(2):201-18. PubMed ID: 24519402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal cost reimbursement of health insurers to reduce risk selection.
    Kifmann M; Lorenz N
    Health Econ; 2011 May; 20(5):532-52. PubMed ID: 20572200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swiss popular initiative for a single health insurer… once again!
    De Pietro C; Crivelli L
    Health Policy; 2015 Jul; 119(7):851-5. PubMed ID: 26004844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries.
    Douven R; Kauer L; Demme S; Paolucci F; van de Ven W; Wasem J; Zhao X
    Eur J Health Econ; 2022 Dec; 23(9):1437-1453. PubMed ID: 35129731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switzerland: Health System Review.
    De Pietro C; Camenzind P; Sturny I; Crivelli L; Edwards-Garavoglia S; Spranger A; Wittenbecher F; Quentin W
    Health Syst Transit; 2015; 17(4):1-288, xix. PubMed ID: 26766626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overpaying morbidity adjusters in risk equalization models.
    van Kleef RC; van Vliet RC; van de Ven WP
    Eur J Health Econ; 2016 Sep; 17(7):885-95. PubMed ID: 26420555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving risk equalization for individuals with persistently high costs: Experiences from the Netherlands.
    Eijkenaar F; van Vliet RCJA
    Health Policy; 2017 Nov; 121(11):1169-1176. PubMed ID: 28942090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An American approach to health system reform.
    Holahan J; Moon M; Welch WP; Zuckerman S
    JAMA; 1991 May; 265(19):2537-40. PubMed ID: 2020072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Falling ill raises the health insurer's administration bill.
    Douven R; Kauer L
    Soc Sci Med; 2023 May; 324():115856. PubMed ID: 37003023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2018 risk-adjustment reform in the Czech Republic: Introducing Pharmacy-based Cost Groups and strengthening reinsurance.
    Bryndová L; Hroboň P; Tulejová H
    Health Policy; 2019 Aug; 123(8):700-705. PubMed ID: 31196570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the distributional impacts of health insurance reform: Evidence from a consumer cost-sharing program.
    Aouad M; Brown TT; Whaley CM
    Health Econ; 2021 Nov; 30(11):2780-2793. PubMed ID: 34418216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk equalization, competition, and choice: a preliminary assessment of the 1993 German health reforms.
    Wysong JA; Abel T
    Soz Praventivmed; 1996; 41(4):212-23. PubMed ID: 8806157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.